loadpatents
Patent applications and USPTO patent grants for Kwon; Mijung.The latest application filed is for "filip1l compositions and methods for treating cancer".
Patent | Date |
---|---|
FILIP1L compositions and methods for treating cancer App 20160176935 - Libutti; Steven K. ;   et al. | 2016-06-23 |
FILIP1L nucleic acid fragments Grant 9,279,009 - Libutti , et al. March 8, 2 | 2016-03-08 |
Filip1l Compositions And Methods For Treating Cancer App 20140039041 - Libutti; Steven K. ;   et al. | 2014-02-06 |
Doc1 Compositions And Methods For Treating Cancer App 20110053850 - Libutti; Steven K. ;   et al. | 2011-03-03 |
Anti-angiogenic polypeptides Grant 7,626,008 - Waisman , et al. December 1, 2 | 2009-12-01 |
Anti-angiogenic Polypeptides App 20090061510 - Waisman; David M. ;   et al. | 2009-03-05 |
Anti-angiogenic polypeptides Grant 7,420,036 - Waisman , et al. September 2, 2 | 2008-09-02 |
Anti-angiogenesis methods, compositions and uses therefor Grant 7,250,271 - Waisman , et al. July 31, 2 | 2007-07-31 |
Anti-angiogenic polypeptides App 20040082030 - Waisman, David M. ;   et al. | 2004-04-29 |
Anti-angiogenesis methods, compositions and uses therefor App 20030083234 - Waisman, David ;   et al. | 2003-05-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.